Logo image of ALGM

ALLEGRO MICROSYSTEMS INC (ALGM) Stock Fundamental Analysis

USA - NASDAQ:ALGM - US01749D1054 - Common Stock

31.45 USD
-0.5 (-1.56%)
Last: 9/19/2025, 8:00:00 PM
31.45 USD
0 (0%)
After Hours: 9/19/2025, 8:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALGM. ALGM was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While ALGM seems to be doing ok healthwise, there are quite some concerns on its profitability. ALGM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGM was profitable.
In the past year ALGM had a positive cash flow from operations.
ALGM had positive earnings in 4 of the past 5 years.
In the past 5 years ALGM always reported a positive cash flow from operatings.
ALGM Yearly Net Income VS EBIT VS OCF VS FCFALGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

ALGM has a Return On Assets of -4.94%. This is in the lower half of the industry: ALGM underperforms 66.07% of its industry peers.
The Return On Equity of ALGM (-7.43%) is worse than 63.39% of its industry peers.
Industry RankSector Rank
ROA -4.94%
ROE -7.43%
ROIC N/A
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ALGM Yearly ROA, ROE, ROICALGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

ALGM has a Gross Margin of 44.39%. This is comparable to the rest of the industry: ALGM outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of ALGM has grown nicely.
The Profit Margin and Operating Margin are not available for ALGM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
ALGM Yearly Profit, Operating, Gross MarginsALGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40

5

2. Health

2.1 Basic Checks

ALGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALGM has been reduced compared to 1 year ago.
ALGM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALGM has a worse debt to assets ratio.
ALGM Yearly Shares OutstandingALGM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ALGM Yearly Total Debt VS Total AssetsALGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 8.34 indicates that ALGM is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALGM (8.34) is better than 66.96% of its industry peers.
The Debt to FCF ratio of ALGM is 6.43, which is on the high side as it means it would take ALGM, 6.43 years of fcf income to pay off all of its debts.
ALGM has a Debt to FCF ratio (6.43) which is in line with its industry peers.
ALGM has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.34, ALGM is doing worse than 65.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 6.43
Altman-Z 8.34
ROIC/WACCN/A
WACC11.46%
ALGM Yearly LT Debt VS Equity VS FCFALGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.70 indicates that ALGM has no problem at all paying its short term obligations.
ALGM has a Current ratio (3.70) which is comparable to the rest of the industry.
A Quick Ratio of 2.26 indicates that ALGM has no problem at all paying its short term obligations.
ALGM has a Quick ratio (2.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 2.26
ALGM Yearly Current Assets VS Current LiabilitesALGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for ALGM have decreased strongly by -70.00% in the last year.
Measured over the past years, ALGM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -32.49% on average per year.
ALGM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.82%.
ALGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)-70%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-18.82%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%21.86%

3.2 Future

Based on estimates for the next years, ALGM will show a very strong growth in Earnings Per Share. The EPS will grow by 83.54% on average per year.
The Revenue is expected to grow by 18.96% on average over the next years. This is quite good.
EPS Next Y122.77%
EPS Next 2Y105.12%
EPS Next 3Y83.54%
EPS Next 5YN/A
Revenue Next Year19.18%
Revenue Next 2Y18.75%
Revenue Next 3Y18.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALGM Yearly Revenue VS EstimatesALGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ALGM Yearly EPS VS EstimatesALGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

ALGM is valuated quite expensively with a Price/Earnings ratio of 104.83.
ALGM's Price/Earnings ratio is in line with the industry average.
ALGM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.38.
The Price/Forward Earnings ratio is 31.14, which means the current valuation is very expensive for ALGM.
The rest of the industry has a similar Price/Forward Earnings ratio as ALGM.
The average S&P500 Price/Forward Earnings ratio is at 22.86. ALGM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 104.83
Fwd PE 31.14
ALGM Price Earnings VS Forward Price EarningsALGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALGM is on the same level as its industry peers.
ALGM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 119.8
EV/EBITDA 114.85
ALGM Per share dataALGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALGM's earnings are expected to grow with 83.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y105.12%
EPS Next 3Y83.54%

0

5. Dividend

5.1 Amount

ALGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALLEGRO MICROSYSTEMS INC

NASDAQ:ALGM (9/19/2025, 8:00:00 PM)

After market: 31.45 0 (0%)

31.45

-0.5 (-1.56%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners85.92%
Inst Owner Change-6.32%
Ins Owners0.68%
Ins Owner Change0.47%
Market Cap5.82B
Analysts83.33
Price Target38.59 (22.7%)
Short Float %7.16%
Short Ratio5.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.39%
Min EPS beat(2)5.14%
Max EPS beat(2)17.65%
EPS beat(4)4
Avg EPS beat(4)13.42%
Min EPS beat(4)5.14%
Max EPS beat(4)25.49%
EPS beat(8)8
Avg EPS beat(8)16.08%
EPS beat(12)12
Avg EPS beat(12)13.14%
EPS beat(16)16
Avg EPS beat(16)11.04%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)0.84%
Max Revenue beat(2)2.03%
Revenue beat(4)2
Avg Revenue beat(4)-0.07%
Min Revenue beat(4)-2.06%
Max Revenue beat(4)2.03%
Revenue beat(8)3
Avg Revenue beat(8)-0.58%
Revenue beat(12)4
Avg Revenue beat(12)-0.23%
Revenue beat(16)7
Avg Revenue beat(16)0.01%
PT rev (1m)0.22%
PT rev (3m)41.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.61%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.33%
Revenue NY rev (1m)1.03%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 104.83
Fwd PE 31.14
P/S 7.64
P/FCF 119.8
P/OCF 65.14
P/B 6.31
P/tB 12.57
EV/EBITDA 114.85
EPS(TTM)0.3
EY0.95%
EPS(NY)1.01
Fwd EY3.21%
FCF(TTM)0.26
FCFY0.83%
OCF(TTM)0.48
OCFY1.54%
SpS4.12
BVpS4.99
TBVpS2.5
PEG (NY)0.85
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.94%
ROE -7.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.39%
FCFM 6.38%
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 6.43
Debt/EBITDA 5.86
Cap/Depr 63.43%
Cap/Sales 5.35%
Interest Coverage N/A
Cash Conversion 168.33%
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 2.26
Altman-Z 8.34
F-Score2
WACC11.46%
ROIC/WACCN/A
Cap/Depr(3y)131.89%
Cap/Depr(5y)124.81%
Cap/Sales(3y)8.59%
Cap/Sales(5y)8.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y122.77%
EPS Next 2Y105.12%
EPS Next 3Y83.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.82%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%21.86%
Revenue Next Year19.18%
Revenue Next 2Y18.75%
Revenue Next 3Y18.96%
Revenue Next 5YN/A
EBIT growth 1Y-108.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.96%
EBIT Next 3Y80.06%
EBIT Next 5YN/A
FCF growth 1Y-49.4%
FCF growth 3Y-37.77%
FCF growth 5Y-10.31%
OCF growth 1Y-56.7%
OCF growth 3Y-26.53%
OCF growth 5Y-5.33%